In general, Aβ contributes to AD pathology by exhibiting toxicity in susceptible neurons, facilitating tau hyperphosphorylation, disrupting proteasome activity, and triggering synaptic dysfunction (LaFerla et al., 2007; Kam et al., 2014). This evidence concerns the gene MAPT and Alzheimer disease.